IP Library Granted Patent US 10,466,249
Granted Patent B2
US 10,466,249 · App. 15/974,923 · Granted Nov 5, 2019

Methods and reagents for analyzing protein-protein interfaces

Inventors: Gregory L. Verdine (Boston, MA); M. James Nichols (Charlestown, MA); Sharon A. Townson (Cambridge, MA); Uddhav Kumar Shigdel (Cambridge, MA); Seung-Joo Lee (Cambridge, MA); Dylan T. Stiles (Chestnut Hill, MA); Neville J. Anthony (Northborough, MA)
Assignee: Revolution Medicines, Inc.
G01N33/6845C07K1/086C07K1/13C07K5/0215C07K5/06034C07K5/0808C07K7/64C07K7/645C12Q1/533G01N33/566G01N2333/82G01N2333/90209G01N2410/08G01N2500/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,466,249
App. No.
15/974,923
Granted
Nov 5, 2019
Kind
B2
Abstract

The present disclosure provides methods and reagents useful for analyzing protein-protein interfaces such as interfaces between a presenter protein (e.g., a member of the FKBP family, a member of the cyclophilin family, or PIN1) and a target protein. In some embodiments, the target and/or presenter proteins are intracellular proteins. In some embodiments, the target and/or presenter proteins are mammalian proteins.

Claims (13)

1. A compound having the structure:

A-L-B

wherein A has the structure of Formula Ila:

wherein Z 1 and Z 2 are each, independently, optionally substituted C 1 -C 6 alkyl, optionally substituted C 1 -C 6 heteroalkyl; and Z 2 includes a point of attachment to the L;

X 2 is absent, CH 2 , O, S, SO, SO 2 , or NR 4 ;

each R 4 is, independently, hydrogen, optionally substituted C 1 -C 6 alkyl, optionally substituted C 2 -C 6 alkenyl, optionally substituted C 2 -C 6 alkynyl, optionally substituted aryl, C 3 -C 7 carbocyclyl, optionally substituted C 6 -C 10 aryl C 1 -C 6 alkyl, and optionally substituted C 3 -C 7 carbocyclyl C 1 -C 6 alkyl;

L is a linker having the structure:

A 1 -(B 1 ) f —(C 1 ) g —(B 2 ) h -(D)-(B 3 ) i —(C 2 ) j —(B 4 ) k -A 2

wherein A 1 is a bond between the linker and A; A 2 is a bond between B and the linker; B 1 , B 2 , B 3 , and B 4 each, independently, is selected from optionally substituted C 1 -C 2 alkyl, optionally substituted C 1 -C 3 heteroalkyl, O, S, and NR N ; R N is hydrogen, optionally substituted C 1 -C 4 alkyl, optionally substituted C 2-4 alkenyl, optionally substituted C 2-4 alkynyl, optionally substituted C 2-6 heterocyclyl, optionally substituted C 6-12 aryl, or optionally substituted C 1-7 heteroalkyl; C 1 and C 2 are each, independently, selected from carbonyl, thiocarbonyl, sulphonyl, or phosphoryl; f, g, h, i, j, and k are each, independently, 0 or 1; and D is optionally substituted C 1-10 alkyl, optionally substituted C 2-10 alkenyl, optionally substituted C 2-10 alkynyl, optionally substituted C 2-6 heterocyclyl, optionally substituted C 6-12 aryl, optionally substituted C 2 -C 10 polyethylene glycol, or optionally substituted C 1-10 heteroalkyl, or a chemical bond linking A 1 -(B 1 ) f 13 (C 1 ) g —(B 2 ) h — to —(B 3 ) i —(C 2 ) j —(B 4 ) k -A 2 ; and

B comprises a cross-linking group, wherein the cross-linking group is a maleimide, vinyl sulfone, isocyanate, isothiocyanate, sulfonyl chloride, acid anhydride, acylazide, imidoester, haloheteroaryl, diazo, carbodiimide, hydrazide, or alkoxyamine,

or a salt thereof.

2. The compound of claim 1 , wherein the cross-linking group is a maleimide or a vinyl sulfone,

or a salt thereof.

Assignments (3)
SECURITY INTEREST Recorded Jun 25, 2025
From: REVOLUTION MEDICINES, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 071721/0025 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2019
From: WARP DRIVE BIO, INC.
To: REVOLUTION MEDICINES, INC.
Reel/Frame 050473/0976 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 22, 2018
From: VERDINE, GREGORY L.; NICHOLS, M. JAMES; TOWNSON, SHARON A.; SHIGDEL, UDDHAV KUMAR; LEE, SEUNG-JOO; STILES, DYLAN T.; ANTHONY, NEVILLE J.
To: WARP DRIVE BIO, INC.
Reel/Frame 045871/0216 →
Continuity (3)
Continuation 15282430 · Sep 30, 2016
Provisional Application 62235896 · Oct 1, 2015
Related Publication 20180259535A1 · Sep 13, 2018
Cited By (8)
US 12,202,845 US 12,252,497 US 12,280,113 US 12,384,750 US 12,403,196 US 12,409,225 US 12,465,643 US 12,540,144